Navigation Links
Fixed-tip AEM Button Tip Electrode

ProductsFixed-tip AEM Button Tip Electrode
Company Encision
Item Fixed-tip AEM Button Tip Electrode
Features 
  • AEM Laparoscopic Instrument
  • Reusable Insert
  • Protective Shield
  • Primary Insulation Layer
  • Outer Insulation
  • Active Electrode Element
    • Description The 5mm AEM Laparoscopic Instruments incorporate a layered design unique in the industry. AEM Instruments are shielded and monitored to prevent stray electrosurgical burns along the shaft of the instrument caused by insulation failure or capacitive coupling; a well-documented patient safety risk. The protective shield built into all AEM Instruments provides a neutral return path for capacitively coupled energy and protection from insulation failure. The shield is continuously monitored during surgery which provides continuous assurance of the integrity of the instrument.

    Encision has a full line of AEM Surgical Instruments that are equivalent in function, ergonomics, size, shape, length and tip-styles as the conventional instruments that surgeons commonly use ... but with the added assurance of patient safety.
    Info Encision
    Customer Service: (303) 444-2600
    Web site: http://www.encision.com/

    Related medicine products :

    1. Fixed-tip AEM Ball Tip Electrode
    2. Fixed-tip AEM Corson Needle Electrode
    3. Fixed-tip AEM Flat Blade Electrode
    4. Fixed-tip AEM J-Hook Electrode
    5. Fixed-tip AEM L-Diamond Electrode
    6. Fixed-tip AEM Needle TIp Electrode
    7. Fixed-tip AEM Short Spatula Electrode
    8. Fixed-tip AEM L-Wedge Electrode
    9. Fixed-tip AEM Spoon Electrode
    10. Fixed-tip AEM Spatula Electrode
    11. Fixed-tip AEM Square-L Electrode
    Breaking Medicine Technology:FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 5Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 6Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 7Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 8Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 9Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 10New study suggests the brain predicts what eyes in motion will see 55304 1New study suggests the brain predicts what eyes in motion will see 55304 2SRNL automakers to develop high performance wireless sensors networks 9693 1SRNL automakers to develop high performance wireless sensors networks 9693 2SRNL automakers to develop high performance wireless sensors networks 9693 3New Data Show ChloraPrep 28R 29 Significantly More Effective Than DuraPrep 28TM 29 and Povidone Iodine in Eliminating Bacteria From Skin Prior to Shou 55300 1New Data Show ChloraPrep 28R 29 Significantly More Effective Than DuraPrep 28TM 29 and Povidone Iodine in Eliminating Bacteria From Skin Prior to Shou 55300 2New Data Show ChloraPrep 28R 29 Significantly More Effective Than DuraPrep 28TM 29 and Povidone Iodine in Eliminating Bacteria From Skin Prior to Shou 55300 3New Data Show ChloraPrep 28R 29 Significantly More Effective Than DuraPrep 28TM 29 and Povidone Iodine in Eliminating Bacteria From Skin Prior to Shou 55300 4New Data Show ChloraPrep 28R 29 Significantly More Effective Than DuraPrep 28TM 29 and Povidone Iodine in Eliminating Bacteria From Skin Prior to Shou 55300 5